vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and MANNATECH INC (MTEX). Click either name above to swap in a different company.

MANNATECH INC is the larger business by last-quarter revenue ($29.2M vs $23.1M, roughly 1.3× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -8.1%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -5.4%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates.

ADCT vs MTEX — Head-to-Head

Bigger by revenue
MTEX
MTEX
1.3× larger
MTEX
$29.2M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+44.4% gap
ADCT
36.4%
-8.1%
MTEX
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-5.4%
MTEX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ADCT
ADCT
MTEX
MTEX
Revenue
$23.1M
$29.2M
Net Profit
$1.9M
Gross Margin
76.4%
Operating Margin
-77.7%
6.9%
Net Margin
6.6%
Revenue YoY
36.4%
-8.1%
Net Profit YoY
686.6%
EPS (diluted)
$0.04
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
MTEX
MTEX
Q4 25
$23.1M
Q3 25
$15.8M
$29.2M
Q2 25
$18.1M
Q1 25
$17.4M
$26.6M
Q4 24
$16.9M
$29.0M
Q3 24
$18.0M
$31.7M
Q2 24
$17.0M
$27.7M
Q1 24
$17.8M
$29.4M
Net Profit
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
$-41.0M
$1.9M
Q2 25
$-56.6M
Q1 25
$-38.6M
$-1.5M
Q4 24
$2.3M
Q3 24
$-44.0M
$-328.0K
Q2 24
$-36.5M
$-624.0K
Q1 24
$-46.6M
$1.2M
Gross Margin
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
76.4%
Q2 25
Q1 25
74.3%
Q4 24
80.6%
Q3 24
74.5%
Q2 24
77.1%
Q1 24
78.6%
Operating Margin
ADCT
ADCT
MTEX
MTEX
Q4 25
-77.7%
Q3 25
-196.6%
6.9%
Q2 25
-244.1%
Q1 25
-163.5%
-3.1%
Q4 24
-191.8%
3.0%
Q3 24
-197.4%
2.8%
Q2 24
-170.5%
-4.1%
Q1 24
-188.3%
2.8%
Net Margin
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
-260.1%
6.6%
Q2 25
-313.2%
Q1 25
-221.8%
-5.8%
Q4 24
7.8%
Q3 24
-244.1%
-1.0%
Q2 24
-214.6%
-2.2%
Q1 24
-261.1%
4.0%
EPS (diluted)
ADCT
ADCT
MTEX
MTEX
Q4 25
$0.04
Q3 25
$-0.30
$1.01
Q2 25
$-0.50
Q1 25
$-0.36
$-0.80
Q4 24
$-0.26
$1.19
Q3 24
$-0.42
$-0.17
Q2 24
$-0.38
$-0.33
Q1 24
$-0.56
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
MTEX
MTEX
Cash + ST InvestmentsLiquidity on hand
$261.3M
$7.1M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$-185.8M
$7.0M
Total Assets
$323.1M
$33.9M
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
MTEX
MTEX
Q4 25
$261.3M
Q3 25
$234.7M
$7.1M
Q2 25
$264.6M
Q1 25
$194.7M
$9.3M
Q4 24
$250.9M
$11.4M
Q3 24
$274.3M
$12.2M
Q2 24
$300.1M
$9.2M
Q1 24
$234.3M
$7.9M
Total Debt
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
$2.9M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ADCT
ADCT
MTEX
MTEX
Q4 25
$-185.8M
Q3 25
$-238.2M
$7.0M
Q2 25
$-199.2M
Q1 25
$-238.2M
$7.6M
Q4 24
$-202.6M
$8.6M
Q3 24
$-171.9M
$10.0M
Q2 24
$-131.7M
$8.2M
Q1 24
$-194.4M
$10.4M
Total Assets
ADCT
ADCT
MTEX
MTEX
Q4 25
$323.1M
Q3 25
$289.8M
$33.9M
Q2 25
$321.6M
Q1 25
$272.5M
$36.7M
Q4 24
$322.0M
$36.1M
Q3 24
$349.1M
$40.6M
Q2 24
$371.8M
$39.9M
Q1 24
$308.0M
$41.1M
Debt / Equity
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
0.42×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
MTEX
MTEX
Operating Cash FlowLast quarter
$-31.1M
$-1.3M
Free Cash FlowOCF − Capex
$-2.0M
FCF MarginFCF / Revenue
-6.8%
Capex IntensityCapex / Revenue
0.0%
2.4%
Cash ConversionOCF / Net Profit
-0.68×
TTM Free Cash FlowTrailing 4 quarters
$-1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
MTEX
MTEX
Q4 25
$-31.1M
Q3 25
$-29.6M
$-1.3M
Q2 25
$-24.1M
Q1 25
$-56.3M
$-1.4M
Q4 24
$-21.9M
$-219.0K
Q3 24
$-25.0M
$3.3M
Q2 24
$-32.8M
$-2.7M
Q1 24
$-44.1M
$1.9M
Free Cash Flow
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
$-2.0M
Q2 25
Q1 25
$-56.6M
$-1.9M
Q4 24
$-21.9M
$-325.0K
Q3 24
$-25.3M
$3.0M
Q2 24
$-32.9M
$-2.7M
Q1 24
$-44.6M
$1.8M
FCF Margin
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
-6.8%
Q2 25
Q1 25
-325.2%
-7.0%
Q4 24
-129.8%
-1.1%
Q3 24
-140.2%
9.5%
Q2 24
-193.0%
-9.9%
Q1 24
-250.0%
6.2%
Capex Intensity
ADCT
ADCT
MTEX
MTEX
Q4 25
0.0%
Q3 25
0.0%
2.4%
Q2 25
0.0%
Q1 25
1.5%
1.8%
Q4 24
0.5%
0.4%
Q3 24
1.2%
0.8%
Q2 24
0.2%
0.3%
Q1 24
3.0%
0.2%
Cash Conversion
ADCT
ADCT
MTEX
MTEX
Q4 25
Q3 25
-0.68×
Q2 25
Q1 25
Q4 24
-0.10×
Q3 24
Q2 24
Q1 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons